Request Free Sample
×
South Korea Morphine Market
ID: MRFR/HC/49738-HCR
200 Pages
May 2025
South Korea Morphine Market Research Report: By Dosage Form (Injection, Oral, Other Dosage Forms), By Application (Pain Management, Diarrhea Suppressant, Cold & Cough Suppressant, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) andBy End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)- Forecast to 2035
Industry Developments
In recent months, the South Korea Morphine Market has seen significant movements with various companies actively engaging in innovations and market strategies. Notably, Janssen has expanded its product offerings focusing on pain management solutions, while Merck has invested in Research and Development to enhance the efficacy of morphine derivatives. Mundipharma has been advocating for better pain management standards across healthcare institutions. In June 2023, SK Biopharmaceuticals reported a strategic partnership with local hospitals to improve access to pain relief medications. Furthermore, in July 2023, Daewoong Pharmaceutical announced the launch of a new morphine formulation intended for specialized patient groups. The valuation of the South Korean morphine market has grown substantially, reflecting increased demand for chronic pain therapies, leading to a competitive landscape among key players including Teva Pharmaceuticals, Novartis, and Roche. In the last two to three years, there have been significant shifts in regulatory policies benefitting manufacturers, especially pertaining to the distribution of controlled substances, thus impacting overall market dynamics. However, no reported mergers or acquisitions have occurred among the specific companies of interest in this timeframe.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 405.0(USD Million) |
| MARKET SIZE 2024 | 431.75(USD Million) |
| MARKET SIZE 2035 | 1103.92(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.909% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Janssen, Merck, Mundipharma, Novartis, Teva Pharmaceuticals, Hanmi Pharmaceutical, SK Biopharmaceuticals, Roche, Daewoong Pharmaceutical, Boehringer Ingelheim, GC Pharma, Pfizer, AstraZeneca, Daiichi Sankyo, Samsung Biologics |
| SEGMENTS COVERED | Dosage Form, Application, Distribution Channel, End User |
| KEY MARKET OPPORTUNITIES | Growing cancer prevalence, Increasing chronic pain management, Expanding palliative care services, Rising geriatric population, Enhanced healthcare infrastructure |
| KEY MARKET DYNAMICS | regulatory environment, pain management prevalence, competition from alternatives, import/export restrictions, pricing pressures |
| COUNTRIES COVERED | South Korea |
FAQs
What is the expected market size of the South Korea Morphine Market in 2024?
The South Korea Morphine Market is expected to be valued at 431.75 million USD in 2024.
What will the market size of the South Korea Morphine Market reach by 2035?
By 2035, the South Korea Morphine Market is projected to grow to 1103.92 million USD.
What is the expected compound annual growth rate (CAGR) for the South Korea Morphine Market from 2025 to 2035?
The CAGR for the South Korea Morphine Market is expected to be 8.909 percent from 2025 to 2035.
Which dosage form of morphine holds the largest market share in 2024?
In 2024, the injection dosage form of morphine holds the largest market share at 250.0 million USD.
How much is the market for oral morphine dosage expected to be in 2035?
The oral morphine dosage market is expected to reach 294.85 million USD by 2035.
Who are the significant competitors in the South Korea Morphine Market?
Major players in the South Korea Morphine Market include Janssen, Merck, Mundipharma, and Novartis among others.
What growth opportunities exist in the South Korea Morphine Market?
There are growth opportunities driven by increasing demand for pain management solutions across healthcare sectors.
What are the projected revenues for 'Other Dosage Forms' of morphine by 2035?
The revenues for 'Other Dosage Forms' of morphine are projected to be 174.27 million USD by 2035.
How will the South Korea Morphine Market be affected by emerging healthcare trends?
Emerging healthcare trends focusing on personalized medicine and chronic pain management are likely to enhance market growth.
What is the expected market size for injection morphine dosage by 2035?
The market size for injection morphine dosage is expected to reach 634.8 million USD by 2035.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense
Leave a Comment